ArticleCancer chemotherapy and pharmacology2022

SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer.

Hai-Yan Piao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.